1 Pot Stock to Buy Instead of CannTrust (TSX:TRST)

As CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) sinks lower, investors should look to this stock instead.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

While the cannabis hype of 2018 might be gone, it’s certainly not forgotten. Investors are still on the hunt for stocks that promise both to be the next big thing with the staying power moving forward as more small producers are snatched up by larger companies.

Thus, when some drama occurs around a fairly well-known stock such as CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST), investors tend to notice.

The marijuana producer is in hot water after Health Canada discovered that it was growing cannabis in five unlicensed rooms. A large portion of CannTrust’s current cannabis inventory was subsequently put on hold by Health Canada, and CEO Peter Aceto was fired.

Analysts have since downgraded the company, with shares plummeting by more than half. In addition, Merchant Law Group LLP has announced it is investigating whether CannTrust violated provincial securities laws, one of several class actions in the works.

Amid the scandal, many investors are wondering whether it’s time to pick up the stock while it’s at all-time lows. However, analysts are warning investors that the stock price could continue dropping, as the company could lose its license.

In my view, the stock is far too much of a gamble at this point.

So what should you buy instead?

Consider Hexo

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) is a far better investment for investors looking to buy up a stock that’s down, but not out. The stock hasn’t been performing the best over the last few months after hitting all-time highs back in April.

The recent drop comes likely from the company announcing that Chief Brand Office and co-founder Adam Miron would be stepping down.

There were no announcements that came with Miron leaving, and no whistle blowers as were with CannTrust, so it does smell a bit fishy.

Looking beyond the potential for scandal, Hexo looks a lot more promising than CannTrust. The company is already heading into the edibles and beverage market after partnering with Molson Coors Canada, but it now plans to enter the market for everyday food products.

According to Health Canada, Canadians should be able to take advantage of the edibles market come December.

Hexo is also an extremely low-cost producer, reporting $2.26 per gram of cannabis sold for its fiscal third quarter — far lower than most of its peers. While the company was among them when it came to reporting a loss of $7.8 million, this was likely down to one-time costs of expanding its operations.

Foolish takeaway

While it can be tempting to buy up stocks on the cheap, investors need to be cautious when it comes to the marijuana market. Hexo provides investors with an opportunity, whereas CannTrust should be seen as a warning.

For investors looking for a bargain, Hexo definitely provides it at this point, either as a company ripe for expansion or ripe for a takeover target.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »